Home - Chinese Journal of Cancer Research

“2019中国中青年医师胃癌手术视频大赛”决赛赛果揭晓，圆满落幕

2019年6月14日下午，在“第十四届全国胃癌学术会议”开幕前夕，由中国抗癌协会胃癌专业委员会和Chinese Journal of Cancer Research 《中国癌症研究》英文杂志共同主办的“2019中国中青年医师胃癌手术视频大赛”决赛在辽宁友谊宾馆迎宾厅圆满结束，经过紧张激烈的现场角逐，来自南方医科大学南方医院的陈韬医生和来自复旦大学附属华山医院的蒿汉坤医生在12名选手中脱颖而出夺得本次比赛的桂冠

重磅来袭——中国国家卫生健康委员会肿瘤诊疗规范英文版！！！（2018年版）

为了适应我国肿瘤领域面临的发展新形势，向国际展示我国肿瘤诊疗的规范化和精准化，推动国内外肿瘤学领域的学术交流，《中国癌症研究》英文杂志(Chinese Journal of Cancer Research，CJCR)组织我国肿瘤领域知名专家学者对国家卫生健康委员会（National Health Commission of the People’s Republic of China, NHCPRC）修订的肿瘤诊疗规范（2018年版）进行编译并出版，以促进我国肿瘤临床研究成果与诊疗经验的国际传播与交流。我们希望通过对肿瘤诊疗规范的编译能够更好地推动全国临床肿瘤学科的规范化建设，帮助各级医务人员提高诊治和研究水平，同时能将更多国际水准、中国特色的研究成果和治疗意见推向国际，造福更多的肿瘤患者。

Cancer incidence and mortality in China, 2014

In 2017, National Central Cancer Registry of China (NCCRC) updated nationwide cancer statistics using population-based cancer registry data in 2014 collected from all available cancer registries. There are 449 cancer registries submitted cancer registry data in 2014, among which 339 registries’ data met the criteria of quality control and were included in analysis. These cancer registries covered 288,243,347 population, accounting for about 21.07% of the national population in 2014. Numbers of nationwide new cancer cases and deaths were estimated using calculated incidence and mortality rates and corresponding national population stratified by area, sex, age group and cancer type. The world Segi’s population was applied for age-standardized rates. Heavy cancer burden and its disparities between area, sex and age group pose a major challenge to public health in China. Nationwide cancer registry plays a crucial role in cancer prevention and control.

Cancer incidence in Beijing, 2014

To analyze cancer incidence data in Beijing in 2014 and temporal trends for selected common cancers during 2005 and 2014. A total of 144 secondary and tertiary hospitals reported newly diagnosed cancer cases to Beijing Cancer Registry, which covers 13 million residents in Beijing. The cancer incidence rate was calculated in strata by cancer type, sex, age group and area. The population composition of China in 1982 and Segi’s population structure were used to calculate age-standardized rates. Extensive procedures were used to assure the quality of the data. A total of 45,300 new cancer cases were diagnosed in Beijing in 2014. The incidence rate was 341.92/100,000 (343.50/100,000 in males, 340.33/100,000 in females). Cancer remains an important public health problem. Actions should be taken to diminish total cancer incidence in Beijing.

‹ ›

Vol 31, No. 5 (October 2019)

Original Article

Cancer burden and trends in China: A review and comparison with Japan and South Korea

Dianqin Sun, Maomao Cao, He Li, Siyi He, Wanqing Chen

Pages: 129-139 HTML

The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC): A report of 2,781 cases in a Chinese population

Yanli Zhu, Yuntao Song, Guohui Xu, Zhihui Fan, Wenhao Ren

Pages: 140-148 HTML

Efficacy of platinum in advanced triple-negative breast cancer with germline BRCA mutation determined by next generation sequencing

Nan Wang, Kun Li, Wenfa Huang, Weiyao Kong, Xiaoran Liu, Weijie Shi, Feng Xie, Hanfang Jiang, Guohong Song, Lijun Di, Quanren Wang, Jianjun Yu, Huiping Li

Pages: 149-162 HTML

Clinicopathological analysis of early-stage breast cancer patients that meet indications for BRCA1/2 genetic testing

Hongyu Xiang, Ling Xin, Qian Liu, Hong Zhang, Shuang Zhang, Jingming Ye, Yuanjia Cheng, Ting Li, Yinhua Liu, Ling Xu

Pages: 163-174 HTML

Evaluation of human epidermal growth factor receptor 2 status of breast cancer using preoperative multidetector computed tomography with deep learning and handcrafted radiomics features

Xiaojun Yang, Lei Wu, Ke Zhao, Weitao Ye, Weixiao Liu, Yingyi Wang, Jiao Li, Hanxiao Li, Xiaomei Huang, Wen Zhang, Yanqi Huang, Xin Chen, Su Yao, Zaiyi Liu, Changhong Liang

Pages: 175-185 HTML

Prognostic value and nomograms of proximal margin distance in gastric cancer with radical distal gastrectomy

Jun Luo, Yuming Jiang, Xinhua Chen, Yuehong Chen, Jhang Lopsang Gurung, Tingyu Mou, Liying Zhao, Guoqing Lyu, Tuanjie Li, Guoxin Li, Jiang Yu

Pages: 186-196 HTML

Analysis and external validation of a nomogram to predict peritoneal dissemination in gastric cancer

Xijie Chen, Shi Chen, Xinyou Wang, Runcong Nie, Dongwen Chen, Jun Xiang, Yijia Lin, Yingbo Chen, Junsheng Peng

Pages: 197-207 HTML

p16/Ki-67 dual-stained cytology used for triage in cervical cancer opportunistic screening

Qin Han, Hongyan Guo, Li Geng, Yanjie Wang

Pages: 208-217 HTML

Phase 1/2 study of concurrent chemoradiotherapy with weekly irinotecan hydrochloride for advanced/recurrence uterine cancer: A multi-institutional study of Kansai Clinical Oncology Group

Satoshi Takeuchi, Haruo Kuroboshi, Taisuke Mori, Kimihiko Ito, Eiji Kondo, Tsutomu Tabata, Yoshio Itani, Ryuji Kawaguchi, Kyosuke Takeuchi, Toshinori Soejima, Ryohei Sasaki

Pages: 218-227 HTML

Nomogram for prediction of pathologic complete remission using biomarker expression and endoscopic finding after preoperative chemoradiotherapy in rectal cancer

Hyuk Hur, Min Soo Cho, Woong Sub Koom, Joon Seok Lim, Tae Il Kim, Joong Bae Ahn, Hoguen Kim, Nam Kyu Kim

Pages: 228-241 HTML

Data mining-based model and risk prediction of colorectal cancer by using secondary health data: A systematic review

Hailun Liang, Lei Yang, Lei Tao, Leiyu Shi, Wuyang Yang, Jiawei Bai, Da Zheng, Ning Wang, Jiafu Ji

Pages: 242-251 HTML

Review Article

Oncometabolic surgery: Emergence and legitimacy for investigation

Won Jun Kim, Yeongkeun Kwon, Chang Min Lee, Seung Hyun Lim, Yong Li, Junjiang Wang, Weixian Hu, Jiabin Zheng, Gang Zhao, Chunchao Zhu, Wei Wang, Wenjun Xiong, Quan Wang, Mingjie Xia, Sungsoo Park

Pages: 252-262 HTML

Evaluation and reflection on claudin 18.2 targeting therapy in advanced gastric cancer

Jianwei Zhang, Ruilan Dong, Lin Shen

Pages: 263-270 HTML

CSCO Guidelines

Updates in version 2019 of CSCO guidelines for colorectal cancer from version 2018

Ying Yuan, Xicheng Wang, Gong Chen, Yi Wang, Weiqi Sheng, Xinxiang Li, Aiping Zhou, Zhen Zhang, Guichao Li, Sanjun Cai, Ruihua Xu, Jin Li, Suzhan Zhang

Pages: 423-425 HTML

Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for head and neck cancer 2018 (English version)

Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for head and neck cancer working group

Pages: 84-98 HTML

Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for persistent/recurrent and metastatic differentiated thyroid cancer 2018 (English version)

Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for persistent/recurrent and metastatic differentiated thyroid cancer working group

Pages: 99-116 HTML

Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for colorectal cancer 2018 (English version)

Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for colorectal cancer working group

Pages: 117-134 HTML